CVR 36089989Entrepreneurial company (IVS)Virksomhedsrådgivning og anden rådgivning om driftsledelse (702200)CharlottenlundFounded 11 Sep 2014
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about MYINNOVLAB IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, 2020
Gross profit
-15.3K
DKK, annual report 2020
-54.2K on 2019
Result
-76.8K
DKK, annual report 2020
Equity
-126.2K
DKK, annual report 2020
SINE KRUSE SIMONSEN HOLDING ApSCVR 36055782, 100% of capital and votes, until 13 Oct 2021
Sine Kruse Simonsenuntil 13 Oct 2021
No current owner is registered.
CVR 36055782100% of capital and votesnotified 27 Jun 201811 Sep 2014 to 13 Oct 2021
CVR 3605580450% to under 66.7% of capital and votesnotified 27 Jun 201811 Sep 2014 to 27 Jun 2018
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
Founded 11 Sep 2014.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Jun 2020, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Jun 2020, published 22 Aug 2020.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2020, DKK: Revenue not reported, Gross profit -15.3K, Operating profit -72.3K, Result for the year -76.8K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2020, DKK: Total assets 33K, Equity -126.2K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 47 | 50 | Not reported | Not reported | Not reported |
| Gross profit | Not reported | Not reported | 163 | 39 | -15 |
| Operating profit | -8 | -53 | +163 | -84 | -72 |
| Result for the year | -14 | -59 | +152 | -89 | -77 |
| Equity | -54 | -113 | 39 | -49 | -126 |
| Total assets | 79 | 34 | 56 | 145 | 33 |
| Employees (average) | Not reported | Not reported | Not reported | 0 | 1 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | -27.4% | 6.6% | Not reported | Not reported | Not reported |
| EBIT margin (overskudsgrad) | -16.7% | -105.9% | Not reported | Not reported | Not reported |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
How each credit metric is calculated:
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for MYINNOVLAB IVS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 1 | None | 1 | None | 1 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Merger (fusion), as the ceasing company (ophørende selskab)
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
5 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en fusionsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende selskaber må antages at være tilstrækkeligt sikrede efter fusionen.
Virksomheden er d. 13.10.2021 opløst ved fusion med CVR-nummer: 36055782 SINE KRUSE SIMONSEN HOLDING IVS.
Vedtægter ændret: 03.01.2019
Direktion:
Fratrådte:
Kenneth Kruse Simonsen, (adm. dir), den 03.01.2019.
Tiltrådte:
Sine Kruse Simonsen, den 03.01.2019.
Formål ændret: Selskabets formål er at drive konsulentvirksomhed, herunder markedsføring, salg og gennemførelse af konsulent- og udviklingsopgaver for private og offentlige virksomheder.
Direktion:
Fratrådte:
Sine Kruse Simonsen, den 01.11.2015.
Tiltrådte:
Kenneth Kruse Simonsen (adm. dir), den 01.11.2015.
Vedtægter ændret:
26.01.2015.
Nyt navn:
MYINNOVLAB IVS.
Stiftelsesdato:
11.09.2014.
Seneste vedtægtsdato:
11.09.2014.
Kapital:
kr. 1,00.
Indbetalingsmåde:
Indbetalt kontant kr. 1,00 til kurs 100,00.
Stiftere:
CVR-NR. 36055804 MARTIN JES RASMUSSEN HOLDING IVS, Assentorpvej 25, 4295 Stenlille, den 11.09.2014, CVR-NR. 36055782 SINE KRUSE SIMONSEN HOLDING IVS, Fortunvej 12, 2920 Charlottenlund, den 11.09.2014.
Direktion:
Sine Kruse Simonsen, den 11.09.2014.
Selskabet tegnes af en direktør.
Første regnskabsår:
11.09.2014 - 31.12.2015.
Regnskabsår:
01.01 - 31.12.
P-number 1019699508Fortunvej 12, 2920 Charlottenlund